Citations

Clear

19 citation(s) found for "Skalski, J".

C32-19 Caught Between Defect and Dysregulation - A Case of Immune Dysregulation in a Patient With Severe Pulmonary Nocardiosis and Chronic Granulomatous Disease
Gyimah, C, Schiavo, D, Skalski, J, Gyimah, C

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.3377 Get It

Abstract Introduction Chronic granulomatous disease (CGD) is an inherited immunodeficiency caused by NADPH oxidase defects, leading to impaired reactive oxygen species (ROS) production and defective intracellular pathogen killing. Typically diagnosed in childhood, CGD manifests as recurrent infections by catalase-positive bacteria and fungi. Immune dysregulation with hyperinflammatory responses may occur even without infection. We present a case of severe immune dysregulation in CGD with concomitant pulmonary nocardiosis. Case Summary A 37-year-old man presented with one month of progressive productive cough, fevers, malaise, vomiting, poor oral intake and high ileostomy output. He was diagnosed with X-linked CGD at age 5 which was complicated by recurrent skin infections and fulminant colitis requiring subtotal colectomy. Laboratory studies showed elevated WBC and CRP of 282.77mg/l. CT scan of chest showed widespread pulmonary nodules and dense consolidation in the left upper lobe with heterogeneous diminished enhancement suggesting necrosis (Fig 1). Cell-free pathogen DNA sequencing testing on sputum identified Nocardia cyriacigeorgica DNA. Fungal cultures on bronchoalveolar lavage grew Nocardia cyriacigeorgica. He was treated with imipinem-cilastin, sulfamethoxazole-trimethoprim, and posaconazole. His course was complicated by refractory fevers (T.max 40.5 C), septic shock, and ARDS. He had two episodes of extubation failure characterized by sudden recrudescence of fever, hemodynamic change, and worsening oxygenation. Each of these episodes occurred during steroid tapers and improved after reinitiating full stress doses. Immune dysregulation was suspected, and he was maintained on 0.8mg/kg/day of methylprednisone with plans for a prolonged taper. He gradually improved, was weaned off oxygen, and discharged home. Discussion Pulmonary nocardiosis is common in CGD, particularly without prophylaxis. Case series report that some patients fail to improve with antimicrobials alone and require adjunctive corticosteroids to control excessive inflammation, as seen in this patient. Immune dysregulation in CGD involves both defective microbial killing and excessive inflammation. Absent ROS results in persistent NF-κB and inflammasome activation, driving production of pro-inflammatory cytokines, leading to granuloma formation, autoimmunity, and IBD-like colitis. Granulomatous inflammation may cause gastrointestinal or genitourinary obstruction, and up to half of patients develop colitis. Exaggerated inflammatory responses to infection or environmental triggers can also mimic hemophagocytic lymphohistiocytosis (HLH). Concurrent susceptibility to infections and inflammation complicates diagnosis and management. Corticosteroids remain first-line for inflammatory episodes and may be combined with antibiotics, as in disseminated nocardiosis, to control hyperinflammation. However, long-term use is limited by adverse effects, and steroid-sparing agents lack proven efficacy in CGD. Hematopoietic stem cell transplantation remains the only curative option in CGD. This abstract is funded by: None
Fungi in the Airways: Associations With Bacterial and Mycobacterial Co-isolation in Patients With Bronchiectasis
Alitelat, Alwatheq , Aksamit, T.R., Chalmers, Sarah , Escalante, Patricio , Peikert, Tobias, Limper, A.H., Kanj, A.N., Patel, Robin , Skalski, Joseph H.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A4552-A4552

10.1164/ajrccm.2025.211.abstracts.a4552 Get It

Abstract RATIONALE: Understanding co-isolation patterns between fungi and other potentially pathogenic microorganisms in the airways of bronchiectasis patients is important for uncovering possible microbial interactions and informing treatment. Although numerous organisms have been identified in respiratory cultures, the specific patterns of their co-isolation are underexplored. OBJECTIVES: To examine the patterns of co-isolation between fungi and bacteria or mycobacteria in respiratory samples from patients with bronchiectasis across a large national health system. METHODS: We reviewed 58,170 respiratory culture tests from 8,194 patients with bronchiectasis (identified using ICD-10-CM codes J47.0, J47.1, and J47.9) across Mayo Clinic. These tests were analyzed for fungal, bacterial, and mycobacterial growth, focusing on co-isolation from the same sample. Chi-square statistics were used to compute p-values. RESULTS: Of all 18,983 samples cultured for fungi, 59% were positive. Of these, 72% yielded yeasts and 40% molds. Among the 11,372 samples cultured for both fungi and bacteria, 681 (6%) showed co-isolation, representing 54% of positive bacterial cultures. The odds of bacterial co-isolation with fungi were 1.4 (95% CI: 1.3-1.6; p < 0.01), driven by yeasts (OR: 1.5, 95% CI: 1.3-1.7; p < 0.01), rather than molds (OR: 1.0, 95% CI: 0.9-1.2; p = 0.8). Pseudomonas species, the most common bacterial isolate, had a higher likelihood of co-isolation with fungi (OR: 1.6, 95% CI: 1.3-1.9; p < 0.01), particularly yeasts (OR: 1.6, 95% CI: 1.4-2.0; p < 0.01). Molds, including those from genera such as aspergillus and penicillium, did not show a significant association with the isolation of pseudomonas. On the other hand, among the 15,859 samples cultured for both fungi and mycobacteria, 1352 (9%) showed co-isolation, representing 62% of positive mycobacterial cultures. Odds of co-isolation were 1.7 (95% CI: 1.5-1.8; p < 0.01). Molds showed a stronger association with isolation of mycobacteria (OR: 1.7, 95% CI: 1.5-1.9; p < 0.01) compared to bacteria, while yeasts also had elevated odds (OR: 1.4, 95% CI: 1.2-1.5). CONCLUSIONS: Distinct patterns of fungal co-isolation with bacteria and mycobacteria have been observed in bronchiectasis, which may influence key aspects of the disease, such as inflammation and mucociliary dysfunction. Advanced metagenomic and immunoprofiling techniques could provide deeper insights into these co-isolation patterns while considering other factors like clinical demographics, previous antibiotic exposure, and disease severity. Understanding whether altering the mycobiome could modify these aspects and improve outcomes remains an important avenue for research.
Higher Asthma Prevalence Among Bronchiectasis Patients With Allergenic Molds in Respiratory Cultures
Chalmers, Sarah , Escalante, Patricio , Peikert, Tobias, Skalski, J., LIMPER, ANDREW H, Aksamit, Timothy R. , Kanj, Amjad , Limper, Andrew H.

Mayo Clinic

C68. NTM: CHALLENGING SCIENCE AND CASES | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A6304-A6304

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6304 Get It

The Microbiome of Idiopathic Subglottic Stenosis in a Tertiary Hospital
Guiance, Irene Riestra , Edell, Eric S. , Ekbom, Dale C. , Kanj, Amjad , Wolff, M., Bayan, Semirra L. , Skalski, Joseph H.

Mayo Clinic

B76. CHRONIC AIRWAY DISEASES: ABOVE AND BEYOND | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A4434-A4434

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4434 Get It

Gut Mycobiome and Asthma
Kanj, Amjad , Skalski, Joseph H. , Kanj, Amjad N

Mayo Clinic

Journal of Fungi | March 1, 2024 | Volume: 10 | Issue: 3 | Pages: 192

10.3390/jof10030192 | PMID 38535201 Get It

This review explores the ‘gut–lung axis’ in asthma with a focus on commensal fungal organisms. We explore how changes to the intestinal commensal fungal community composition alter lung immune function. We comprehensively review available studies that have profiled the composition of the gut mycobiome in adults and children with asthma, and discuss mechanisms of gut–lung interactions that have been described in animal models of asthma. Studies indicate that intestinal fungal dysbiosis, such as an increased abundance of certain fungi like Candida, can elevate the risk of asthma in children and exacerbate it in adults. This effect is mediated through various pathways: the host immune system’s sensing of dysbiosis via C-type lectin receptors (e.g., Dectin-2), the impact of pro-inflammatory fungal metabolites (e.g., 12,13-diHOME, prostaglandin E2), and the role of lung immune cells (e.g., group 2 innate lymphoid cells [ILC2], M2 macrophages). We also describe strategies for modulating the gut mycobiome as potential therapies for severe asthma. The review concludes by emphasizing the necessity for further research into the role of the gut mycobiome in asthma to deepen our understanding of these complex interactions.
The intestinal commensal fungus Wallemia mellicola enhances asthma in mice through Dectin-2
Kanj, Amjad , Guiance, Irene Riestra , Kottom, Theodore J. , Schaefbauer, Kyle, Kanj, Amjad N , Schaefbauer, Kyle J., Choudhury, Malay , Skalski, Joseph H. , Kottom, Theodore J , Limper, Andrew H.

Mayo Clinic

Medical Mycology | February 9, 2024 | Volume: 62 | Issue: 2 | Pages: No page available

10.1093/mmy/myae004 | PMID 38331424 Get It

Abstract Overgrowth of the fungus Wallemia mellicola in the intestines of mice enhances the severity of asthma. Wallemia mellicola interacts with the immune system through Dectin-2 expressed on the surface of myeloid and intestinal epithelial cells. Using Dectin-2-deficient mice, we show that the interaction of W. mellicola with Dectin-2 is essential for the gut-lung pathways, enhancing the severity of asthma in mice with W. mellicola intestinal dysbiosis. These findings offer better insight into dysbiosis-associated inflammation and highlight the role pattern recognition receptors have in immune recognition of commensal fungi in the gut, leading to alterations in immune function in the lungs.
Attributes Influencing the Selection of Fellowship Programs by Pulmonary and Critical Care Applicants: A Pilot Study
Kelm, Diana J. , Nelson, Darlene R. , Lee, Augustine S. , Wesselius, Lewis , Ramar, Kannan , Skalski, Joseph H. , Wesselius, Lewis J, Kashani, Kianoush

Mayo Clinic

Annals of the American Thoracic Society | July 12, 2022 | Volume: 13 | Issue: 4 | Pages: 572-574

10.1513/annalsats.201601-032le | PMID 27058187 Get It

Dectin-2 Recognizes Gut Dysbiosis of the Commensal Fungi Wallemia Mellicola and Is Essential for the Gut-Lung Axis Interactions Aggravating Asthma in Murine Models
Kanj, A.N., Kottom, T., Choudhury, M., Schaefbauer, K., Limper, A.H., Skalski, J., Kottom, Theodore J.

Mayo Clinic

C21. DRILLING DOWN ON INFLAMMATORY MECHANISMS IN ASTHMA VIA HUMAN CELLS AND MURINE MODELS | May 24, 2022 | Volume: No volume available | Issue: No issue available | Pages: A5685-A5685

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5685 Get It

Mechanisms by Which Gut-Lung Axis Interactions Enhance Asthma Severity: The Dysbiosis-Associated Fungus Wallemia MellicolaSignals via Dectin-2/CARD9 Pathway
Kanj, A.N., Kottom, T., Schaefbauer, K., Limper, A.H., Skalski, J., Kottom, Theodore J.

Mayo Clinic

TP9. TP009 MECHANISTIC AND TRANSLATIONAL ASTHMA STUDIES | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1413-A1413

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1413 Get It

Hold the Valve, a Challenging Case of Persistent Air Leak
Zhang, Z., Stroh, G., Cano, E.J., Skalski, J., Skalski, J.

Mayo Clinic

A57. NTM: CASE REPORTS | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A2035-A2035

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2035 Get It